National Institute for Materials Science (物質・材料研究機構 Busshitsu-zairyō kenkyū kikō) is an Independent Administrative Institution and one of the largest scientific research centers in Japan.

Chiesi Farmaceutici SpA develops and markets pharmaceutical products. The firm specializes in research, development and production of drugs in respiratory dosage forms, such as metered-dose inhalers and sterile unit dose vials. The company was founded by Giacomo Chiesi in 1935 and is headquartered in Parma, Italy.

Shanghai Renkang Technology Co., Ltd., established on 1998-11-11, Business scope includes medical devices,Chemical raw materials and products(Removal of hazardous chemicals,Monitor Chemicals,firecrackers,civilian explosives,precursor chemicals)Sales;Engaged in technical development in the field of medical device technology,technical consulting,technology transfer . [Items subject to approval by law,Business activities can only be carried out after approval by relevant departments]

Beijing Jayyalife Biological Technology Co., Ltd. is a private company headquartered in Beijing, China, that provides internet services. It was founded in 1995.

Celularity, Inc. a clinical stage biotechnology company, which engages in the development of off-the-shelf placental-derived allogeneic cell therapies for the treatment of cancer and immune and infectious diseases. It operates through the following segments: Cell Therapy, BioBanking, Degenerative Disease, and Other. The Cell Therapy segment consists of the therapies the company is researching and developing. The BioBanking segment focuses on stem cells from umbilical cords and placentas and provides storage of such cells on behalf of individuals for future use. The Degenerative Disease segment offers products used in surgical and wound care markets. The company was founded by Robert J. Hariri in 2016 and is headquartered in Florham Park, NJ.

The National Space Development Agency (宇宙開発事業団 Uchū Kaihatsu Jigyōdan) of Japan, or NASDA, was a Japanese national space agency established on October 1, 1969 under the National Space Development Agency Law only for peaceful purposes. Based on the Space Development Program enacted by the Minister of Education, Culture, Sports, Science and Technology (MEXT), NASDA was responsible for developing satellites and launch vehicles as well as launching and tracking them.

Cardeas Pharma is developing a novel antibiotic formulation of two drugs with synergistic activity against all relevant, highly resistant Gram-negative bacilli, including Pseudomonas aeruginosa, Acinetobacter baumannii, and carbapenem-resistant Enterobacteriaceae. In addition, this antibiotic formulation has activity on biofilms. The combination also has activity against Gram-positive pathogens including methicillin-resistant Staphylococcus aureus (MRSA). This formulation is administered using a single-patient use, vibrating-plate nebulizer that is compatible with all ventilators. The nebulizer creates small, uniform aerosol droplets that deliver drug to the small airways and alveoli. Integration of this novel antibiotic formulation and device has the potential to achieve significant clinical outcomes relative to current standard therapy.

PRE Holdings, Inc., along with its subsidiaries PRE Solutions, Inc. and ITC Financial Services LLC, provided prepaid transaction processing solutions. PRE's product line included prepaid wireless airtime, long-distance cards, gift cards, music downloads, ringtones and games, online games, the Mio(TM) Money Prepaid MasterCard(R) and the Mio(TM) Now Card. The firm was located in Norcross, GA.

Wuhu Traditional Chinese Medicine Ling Life Technology Co., Ltd., established on 2014-09-03, Business scope includes research and development of biotechnology products,Sales,technical consulting,Transformation of scientific and technological achievements(country restrictions,Except prohibited);Medical device management(Carry out business in accordance with the business scope approved by the medical device business license).(The above business scope involves the national restricted category,Except prohibited items,Except for projects involving pre-licensing,Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Anthrogenesis, based in Cedar Knolls, New Jersey, is a biotherapeutics company that has developed proprietary methods for collecting, processing and storing stem cells and other valuable biomaterials derived from human placental tissue. Anthrogenesis is focused on developing and delivering therapies using stem cells sourced from human placental tissue to treat cancers and immunological, metabolic and inflammatory diseases. Anthrogenesis has demonstrated that the human placenta is an abundant source of biotherapies, including early stage stem cells and other biomaterials for organ and tissue repair. Anthrogenesis also operates Lifebank, a state-licensed blood bank that banks stem cell transplant units derived from placental tissue and in some cases, blood from the umbilical cord that is collected immediately after birth.

Part of Shandong Weigao Group Medical Polymer Co. Ltd., Weihai Jierui Medical Products Co., Ltd. is a Chinese company located in Weihai that manufactures and sells medical polymer products. Hong Feng Ju is the CEO, in this role since 2020.